| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |